Morphine Maintenance Treatment of Opioid-Dependent Out-Patients

European Addiction Research

Volumn 2, Issue 4, 1996, Pages 208-212

  Moldovanyi, Andreas ^a   Ladewig, Dieter ^a   Affentranger, Pierre ^b   Natsch, Claudius ^a   Stohler, Rudolf ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b FEDERAL OFFICE OF PUBLIC HEALTH   (Switzerland)

Author keywords

Morphine; Morphine substitution treatment; Side effects

Indexed keywords

MORPHINE; OPIATE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DEPENDENCE; EDEMA; ERYTHEMA; FEMALE; HEADACHE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAINTENANCE THERAPY; MALE; METHADONE TREATMENT; ORAL DRUG ADMINISTRATION; OUTPATIENT; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; SWITZERLAND; URTICARIA;

EID: 0029860014     PISSN: 10226877     EISSN: 14219891     Source Type: Journal    
DOI: 10.1159/000259134     Document Type: Article

References (13)

1. Schulzeck S, Gleim M, Maier C: Morphine tablets for chronic non-tumor-induced pain. Which factors modify the success or failure of a longterm therapy? Anaesthesist 1993;42:545-556.
2. Sorge J: Use of strong opioids in the treatment of cancer pain in adults and children. Klin Padiatr 1989;20:333-336.
3. Sorge J, Lehmkuhl C, Lohse K, Hermann H, Pichlmayr I: Long-term therapy of tumor pain using morphine-retard tablets. Med Klin 1990; 15:523-528.
4. McKenzie R. Rudy T. Ponter-Hammill H: Side effects of morphine patient-controlled analgesia and meperidine patient-controlled analgesia: A follow-up of 500 patients. AANAJ 1992; 60:282-286.
5. France RD, Urban BJ, Keefe FJ: Long-usc of narcotic analgesics in chronic pain. Soc Sci Med 1984;19:1379-1382.
6. Choiniere M, Grenier R, Paquette C: Patient-controlled analgesia: A double-blind study in bum patients. Anaesthesia 1992;47:467-472.
7. Arkinstall WW, Goughnour BR, White JA, Stewart JH: Control of severe pain with sustain-ned-release morphine tablets v. oral morphine solution. Can Med Assoc J 1989:653-7:661.
8. Derks JT: The dispensing of injectable morphine in Amsterdam: Experiences, results and implications for the Swiss Project for the medical prescription of narcotics; in The Medical Prescription of Narcotics. Bern. Huber, in press.
9. Bundesamt für Gesundheitswesen: Versuche für eine ärztliche Verschreibung von Betäubungsmitteln. Gesamtversuchsplan und Ausführungsbestimmungen. Bern. Bundesamt für Gesundheitswesen, 1993.
10. Stellato C, Cirillo R, de Paulis A, Casolaro V, Patella V, Mastronardi P. Mazzarella B, Ma-rone G: Human basophil/mast cell releasabili-ty. IX. Heterogcnity of the effects of opioids on mediator release. Anesthesiology 1992;77:932-940.
11. Fjellner B, Hagermark O: The influence of the opiate antagonist naloxone on experimental pruritus. Acta Derm Venereol (Stockh) 1984; 64:73-75.
12. Tharp MD. Kagey-Sobotka A, Fox CC, Ma-rone G, Lichtenstein LM, Sullivan TJ: Functional heterogeneity of human mast cells from different anatomic sites: In vitro responses to morphine sulfate. J Allergy Clin Immunol 1987;79:646-653.
13. Long WF, Taylor RJ, Wagner CJ, Leavengood DC, Nelson HS: Skin test suppression by antihistamines and the development of subsensitivity. J Allergy Clin Immunol 1985:76:113-117.